Quantcast
Last updated on April 17, 2014 at 9:59 EDT

SL Chapman releases FREE Special Report: 7 Things You Must Know About Pradaxa Complications

April 26, 2012

The Pradaxa Lawyers Special Report details homorrhagic stroke, gastrointestinal bleeding, internal bleeding and heart attack concerns related to the drug. The Federal Drug Administration has opened an investigation concerning Pradaxa side effects.

St. Louis, MO (PRWEB) April 26, 2012

SL Chapman law firm has released a FREE Special Report on the drug Pradaxa® titled “7 Things You Must Know About Pradaxa Complications.” Firm Founding Partner Bradley Lakin said, “We´ve created this Free Special Report for users of Pradaxa to help them access as much information about the drug as possible. Recent studies and FDA advisories indicate Pradaxa can lead to death, gastrointestinal bleeding, internal bleeding and increased risk of heart attack. ”

The Pradaxa lawyers´ free report can be accessed by clicking here. This is a valuable report for people, or their loved ones, who have suffered Pradaxa complications.

SL Chapman partner and leading Pradaxa attorney Robert Evola said, “those with certain medical conditions or those taking other medications are at an even greater risk for experiencing complications with Pradaxa; internal bleeding is one major symptom.”

The firm´s Pradaxa lawyers are nationally known litigators whose credentials include SuperLawyers© and Top 100 Trial Lawyers accolades. SL Chapman has offices in St. Louis, Phoenix and Southern Illinois. The attorneys of SL Chapman have obtained over $ 700 million in verdicts, settlements, and other benefits for their clients. The firm´s practice areas include personal injury, pharmaceutical, commercial, estate planning and other complex litigation. The Pradaxa attorneys at SL Chapman offer this free Special Report (click here) to those who have suffered from internal bleeding or other side effects from the drug.

For the original version on PRWeb visit: http://www.prweb.com/releases/prweb2012/4/prweb9433522.htm


Source: prweb